RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Richard LeBaron to Humans

This is a "connection" page, showing publications Richard LeBaron has written about Humans.
Connection Strength

0.094
  1. Phelix CF, Bourdon AK, Villareal G, LeBaron RG. Modeling non-clinical and clinical drug tests in Gaucher disease. Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug; 2016:1434-1438.
    View in: PubMed
    Score: 0.028
  2. Zamilpa R, Rupaimoole R, Phelix CF, Somaraki-Cormier M, Haskins W, Asmis R, LeBaron RG. C-terminal fragment of transforming growth factor beta-induced protein (TGFBIp) is required for apoptosis in human osteosarcoma cells. Matrix Biol. 2009 Jul; 28(6):347-53.
    View in: PubMed
    Score: 0.017
  3. Riojas MA, Villanueva-Vedia RE, Zamilpa R, Chen X, Du LC, Phelix CF, LeBaron RG. Prevalence of diabetes mellitus and correlation of urinary transforming growth factor-beta1 with blood hemoglobin A1C in the Atascosa Diabetes Study. Ethn Dis. 2008; 18(2 Suppl 2):S2-54-9.
    View in: PubMed
    Score: 0.015
  4. Mondragon AA, Betts-Obregon BS, Moritz RJ, Parvathaneni K, Navarro MM, Kim HS, Lee CF, LeBaron RG, Asmis R, Tsin AT. BIGH3 protein and macrophages in retinal endothelial cell apoptosis. Apoptosis. 2015 Jan; 20(1):29-37.
    View in: PubMed
    Score: 0.006
  5. Phelix CF, Villareal G, LeBaron RG, Roberson DJ. Biomarkers from biosimulations: Transcriptome-To-Reactome? Technology for individualized medicine. Annu Int Conf IEEE Eng Med Biol Soc. 2014; 2014:3452-5.
    View in: PubMed
    Score: 0.006
  6. Bauereis B, Haskins WE, Lebaron RG, Renthal R. Proteomic insights into the protective mechanisms of an in vitro oxidative stress model of early stage Parkinson's disease. Neurosci Lett. 2011 Jan 13; 488(1):11-6.
    View in: PubMed
    Score: 0.005
  7. Ghosh S, Albitar L, LeBaron R, Welch WR, Samimi G, Birrer MJ, Berkowitz RS, Mok SC. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer. Gynecol Oncol. 2010 Oct; 119(1):114-20.
    View in: PubMed
    Score: 0.005
  8. True LD, Hawley S, Norwood TH, Braun KR, Evanko SP, Chan CK, LeBaron RC, Wight TN. The accumulation of versican in the nodules of benign prostatic hyperplasia. Prostate. 2009 Feb 01; 69(2):149-58.
    View in: PubMed
    Score: 0.004
  9. Suwiwat S, Ricciardelli C, Tammi R, Tammi M, Auvinen P, Kosma VM, LeBaron RG, Raymond WA, Tilley WD, Horsfall DJ. Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res. 2004 Apr 01; 10(7):2491-8.
    View in: PubMed
    Score: 0.003
  10. Sakko AJ, Ricciardelli C, Mayne K, Suwiwat S, LeBaron RG, Marshall VR, Tilley WD, Horsfall DJ. Modulation of prostate cancer cell attachment to matrix by versican. Cancer Res. 2003 Aug 15; 63(16):4786-91.
    View in: PubMed
    Score: 0.003
  11. Temenoff JS, Athanasiou KA, LeBaron RG, Mikos AG. Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J Biomed Mater Res. 2002 Mar 05; 59(3):429-37.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support